ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9636
-0.12%
Brent Oil
83.145
0.02%
Bitcoin
63,859.98
-0.22%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Hemogenyx Pharmaceuticals Plc (HEMO)

  7. Hemogenyx Pharmaceuticals Plc (HEMO) Noticias

HEMO Hemogenyx Pharmaceuticals Plc

1.565
-0.002 (-0.13%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Hemogenyx Pharmaceuticals Plc HEMO London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.002 -0.13% 1.565 10:35:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.53 1.53 1.53 1.565 1.567
más cotizaciones de acciones »
Sector Industrial de la empresa
PHARMACEUTICALS & BIOTECHNOLOGY

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202406:19ALNCNewsEARNINGS: LSL starts 2024 "strongly"; Focusrite maintains..
25/4/202401:00UK RNSHemogenyx Pharmaceuticals PLC Final Results
28/3/202402:00UK RNSHemogenyx Pharmaceuticals PLC Total Voting Rights
29/2/202408:04ALNCNewsHemogenyx Pharmaceuticals raises money for leukaemia..
29/2/202401:00UK RNSHemogenyx Pharmaceuticals PLC Placing to Raise US$4.2..
16/2/202405:27ALNCNewsHemogenyx shares rise on potential for CBR to treat brain..
16/2/202401:00UK RNSHemogenyx Pharmaceuticals PLC CBR Brain Delivery
14/2/202404:14ALNCNewsHemogenyx says CBR can be used intranasally to treat viral..
14/2/202401:00UK RNSHemogenyx Pharmaceuticals PLC CBR Intranasal Delivery
09/2/202404:00ALNCNewsIN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T..
09/2/202401:00UK RNSHemogenyx Pharmaceuticals PLC FDA Consents to Phase I Trials..
02/2/202404:44ALNCNewsIN BRIEF: Hemogenyx hails US patent application progress
02/2/202401:00UK RNSHemogenyx Pharmaceuticals PLC Approval and Issuance of U.S...
16/1/202405:13ALNCNewsHemogenyx Pharmaceuticals sends complete response on..
16/1/202401:00UKREGHemogenyx Pharmaceuticals PLC Submission of Complete..
08/1/202404:56ALNCNewsHemogenyx Pharmaceuticals completes process qualification..
08/1/202401:00UKREGHemogenyx Pharmaceuticals PLC HEMO-CAR-T Process..
28/11/202310:53ALNCNewsTRADING UPDATES: Upland Resources completes technical study..
28/11/202306:19UKREGHemogenyx Pharmaceuticals PLC Placing to Raise GBP534,375
27/11/202304:52ALNCNewsHemogenyx shares up as says CBR platform a potential cancer..
27/11/202301:00UKREGHemogenyx Pharmaceuticals PLC CBR Expanded to Treatment of..
15/11/202309:43ALNCNewsHemogenyx Pharmaceuticals completes lentivirus..
15/11/202301:00UKREGHemogenyx Pharmaceuticals PLC Lentivirus Re-manufacturing..
31/10/202302:00UKREGHemogenyx Pharmaceuticals PLC Total Voting Rights
28/9/202308:24ALNCNewsEARNINGS: Dar Global profit multiplies, Hemogenyx loss..
28/9/202306:28UKREGHemogenyx Pharmaceuticals PLC Half-year Report
18/9/202308:37ALNCNewsTRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells..
18/9/202301:00UKREGHemogenyx Pharmaceuticals PLC Strategic Investment from..
14/9/202308:31ALNCNewsHemogenyx Pharma says US FDA accepts Hemo-Car-T clinical..
14/9/202303:11DJNHemogenyx Pharmaceuticals Says FDA Accepted Plans to Address..
14/9/202301:00UKREGHemogenyx Pharmaceuticals PLC Clinical Hold Lift Plan is..
08/9/202313:43ALNCNewsIN BRIEF: Hemogenyx Pharmaceuticals says patent number..
08/9/202311:11RNSNONHemogenyx Pharmaceuticals PLC CBR Patent Application Update
10/7/202304:27ALNCNewsHemogenyx says Hemo-Car-T treatment placed on clinical hold..
10/7/202303:15DJNHemogenyx Pharmaceuticals Addresses FDA Concern on Leukemia..
10/7/202301:00UKREGHemogenyx Pharmaceuticals PLC Full FDA Review for HEMO-CAR-T..
30/6/202310:07UKREGHemogenyx Pharmaceuticals PLC Result of Annual General..
02/6/202308:01UKREGHemogenyx Pharmaceuticals PLC Posting of Annual Report &..
02/6/202307:08ALNCNewsIN BRIEF: Hemogenyx announces clinical hold for Hemo-Car-T..
02/6/202306:14DJNHemogenyx Pharmaceuticals Shares Fall After FDA Puts..
02/6/202305:24UKREGHemogenyx Pharmaceuticals PLC Clinical Hold on IND for..
09/5/202309:16ALNCNewsIN BRIEF: Hemogenyx submits FDA application for Hemo-Car-T..
09/5/202301:00UKREGHemogenyx Pharmaceuticals PLC Submission of IND for..

Su Consulta Reciente

LSE
HEMO
Hemogenyx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados